Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JAM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGFLR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CDK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR7112 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CBL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLEC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DERL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS37B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RSRC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDFIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INPP5F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on